DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 115 filers reported holding DENALI THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11 | -31.2% | 546 | 0.0% | 0.00% | – |
Q2 2023 | $16 | +23.1% | 546 | 0.0% | 0.00% | – |
Q1 2023 | $13 | -13.3% | 546 | 0.0% | 0.00% | – |
Q4 2022 | $15 | -99.9% | 546 | +19.2% | 0.00% | – |
Q3 2022 | $14,000 | +7.7% | 458 | 0.0% | 0.00% | – |
Q2 2022 | $13,000 | +18.2% | 458 | +28.7% | 0.00% | – |
Q1 2022 | $11,000 | -31.2% | 356 | 0.0% | 0.00% | – |
Q4 2021 | $16,000 | -23.8% | 356 | -14.6% | 0.00% | – |
Q3 2021 | $21,000 | +10.5% | 417 | +73.8% | 0.00% | – |
Q2 2021 | $19,000 | +35.7% | 240 | 0.0% | 0.00% | – |
Q1 2021 | $14,000 | -26.3% | 240 | +6.2% | 0.00% | – |
Q4 2020 | $19,000 | -9.5% | 226 | -61.5% | 0.00% | – |
Q3 2020 | $21,000 | +110.0% | 587 | 0.0% | 0.00% | – |
Q2 2020 | $10,000 | 0.0% | 587 | 0.0% | 0.00% | – |
Q1 2020 | $10,000 | +11.1% | 587 | +8.3% | 0.00% | – |
Q4 2019 | $9,000 | 0.0% | 542 | -10.3% | 0.00% | – |
Q3 2019 | $9,000 | -30.8% | 604 | 0.0% | 0.00% | – |
Q2 2019 | $13,000 | -7.1% | 604 | 0.0% | 0.00% | – |
Q1 2019 | $14,000 | -12.5% | 604 | -21.0% | 0.00% | – |
Q4 2018 | $16,000 | – | 765 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 7,460,732 | $240,012,000 | 28.78% |
Casdin Capital, LLC | 1,500,000 | $48,255,000 | 2.16% |
Flagship Pioneering Inc. | 2,619,968 | $84,284,000 | 1.98% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 38,000 | $8,192,000 | 1.85% |
Yiheng Capital Management, L.P. | 1,014,684 | $32,642,000 | 1.49% |
SECTORAL ASSET MANAGEMENT INC | 207,100 | $6,662,000 | 1.18% |
Artal Group S.A. | 600,000 | $19,302,000 | 0.81% |
GILDER GAGNON HOWE & CO LLC | 2,619,217 | $84,260,000 | 0.78% |
Temasek Holdings (Private) Ltd | 5,369,487 | $172,736,397 | 0.73% |
BRANDYWINE MANAGERS, LLC | 9,601 | $309,000 | 0.53% |